BTLA / CD272 Reference Antibody (Tifcemalimab)

SKU: orb1818167

Description

Recombinant Antibody

Images & Validation

−

Item 1 of 2

Tested Applications	FC, Kinetics
Reactivity	Human

Key Properties

−

Antibody Type	Primary Antibody
Clonality	Monoclonal
Isotype	IgG4
Source/Expression System	CHO Cell
Protein Sequence	BTLA / CD272
Molecular Weight	146 Da
Endotoxin	< 0.001EU/μg,determined by LAL method.
Conjugation	Unconjugated

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Form/Appearance	Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column.
Concentration	1mg/ml
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

B- and T-lymphocyte attenuator, B- and T-lymphocyte-associated protein, CD272, BTLA {ECO:0000303|PubMed:12796776, ECO:0000312|HGNC:HGNC:21087}

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

The purity of Anti-BTLA / CD272 Reference Antibody (Tifcemalimab) is more than 98.17%, determined by SEC-HPLC.

Anti-BTLA / CD272 Reference Antibody (Tifcemalimab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%

Quick Database Links

UniProt

Q7Z6A9

UniProt Details

−

No UniProt data available

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Flow Cytometry

View Protocol

Find More Protocols